ImmunoPrecise Antibodies
(NASDAQ:IPA)
$1.24
-0.03[-2.36%]
At close: Apr 15
$1.24
0[0.00%]
PreMarket: 7:15PM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

ImmunoPrecise Antibodies Stock (NASDAQ:IPA), Quotes and News Summary

ImmunoPrecise Antibodies Stock (NASDAQ: IPA) stock price, news, charts, stock research, profile.

Open-
Close-
Volume / Avg.0 / 588.034K
Day Range- - -
52 Wk Range0.940 - 4.220
Market Cap$32.631M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
34
Short Interest
1.38%
Days to Cover1.35

Recent News

EXCLUSIVE: Immunoprecise Antibodies and InterSystems Integrate Vector Search With LENSai For AI-Driven Healthcare Applications
Immunoprecise Antibodies partners with InterSystems to integrate Vector Search of IRIS data platform with BioStrand's LENSai for AI-driven healthcare solutions. Revolutionize drug discovery with precise, scalable data analysis.
Vandana Singh
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results.
Avi Kapoor
Sponsored
ImmunoPrecise Antibodies (NASDAQ: IPA) Is Changing How We Look At The Complex World Of Antibody Discovery
Even though we speak, listen, read and write every day, language is incredibly complex and ever-evolving. Context is critical to understanding. In the English language, there are a plethora of words that are spelled the same but have vastly different meanings depending on their context.
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.0
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
ImmunoPrecise Antibodies Ltd is a supplier of custom antibodies to the research industry and industr...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
IPA

FAQ

Q

How do I buy ImmunoPrecise Antibodies (IPA) stock?

A

You can purchase shares of ImmunoPrecise Antibodies (NASDAQ: IPA) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are ImmunoPrecise Antibodies's (IPA) competitors?

A

There are no as such competitors for ImmunoPrecise Antibodies.

Q

What is the target price for ImmunoPrecise Antibodies (IPA) stock?

A

The latest price target for ImmunoPrecise Antibodies (NASDAQ: IPA) was reported by Benchmark on Friday, March 15, 2024. The analyst firm set a price target for 5.00 expecting IPA to rise to within 12 months (a possible 303.23% upside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for ImmunoPrecise Antibodies (IPA)?

A

The stock price for ImmunoPrecise Antibodies (NASDAQ: IPA) is $1.24 last updated April 15, 2024 at 7:15 PM EDT.

Q

Does ImmunoPrecise Antibodies (IPA) pay a dividend?

A

There are no upcoming dividends for ImmunoPrecise Antibodies.

Q

When is ImmunoPrecise Antibodies (NASDAQ:IPA) reporting earnings?

A

ImmunoPrecise Antibodies’s Q4 earnings are confirmed for Friday, July 5, 2024.

Q

Is ImmunoPrecise Antibodies (IPA) going to split?

A

There is no upcoming split for ImmunoPrecise Antibodies.

Q

What sector and industry does ImmunoPrecise Antibodies (IPA) operate in?

A

ImmunoPrecise Antibodies is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.